TRMT6 and urogenital neoplasm: Interestingly, 8 out of the 9 tRF-3 targets repressed by siTRMT6/61A (Fig. 6e) showed a significant positive correlation in expression with TRMT6 in TCGA bladder patient samples (Fig. 7h and Supplementary Fig. 7f).